BG25518A3 - A method of obtaining xantain derivatives - Google Patents

A method of obtaining xantain derivatives

Info

Publication number
BG25518A3
BG25518A3 BG032887A BG3288775A BG25518A3 BG 25518 A3 BG25518 A3 BG 25518A3 BG 032887 A BG032887 A BG 032887A BG 3288775 A BG3288775 A BG 3288775A BG 25518 A3 BG25518 A3 BG 25518A3
Authority
BG
Bulgaria
Prior art keywords
xantain
derivatives
obtaining
xantain derivatives
obtaining xantain
Prior art date
Application number
BG032887A
Other languages
Bulgarian (bg)
English (en)
Inventor
Wilhelm Ronz
Richard Reichl
Original Assignee
Неизвестен
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Неизвестен filed Critical Неизвестен
Publication of BG25518A3 publication Critical patent/BG25518A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/10—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG032887A 1974-12-21 1975-12-19 A method of obtaining xantain derivatives BG25518A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19742460929 DE2460929A1 (de) 1974-12-21 1974-12-21 Neue xanthinderivate, verfahren zu ihrer herstellung und ihre anwendung

Publications (1)

Publication Number Publication Date
BG25518A3 true BG25518A3 (en) 1978-10-10

Family

ID=5934312

Family Applications (1)

Application Number Title Priority Date Filing Date
BG032887A BG25518A3 (en) 1974-12-21 1975-12-19 A method of obtaining xantain derivatives

Country Status (31)

Country Link
US (1) US3998953A (da)
JP (1) JPS5188995A (da)
AT (1) AT341540B (da)
AU (1) AU501889B2 (da)
BE (1) BE836898A (da)
BG (1) BG25518A3 (da)
CA (1) CA1036159A (da)
CH (1) CH628346A5 (da)
CS (1) CS191289B2 (da)
DD (1) DD124984A5 (da)
DE (1) DE2460929A1 (da)
DK (1) DK137677C (da)
ES (2) ES443738A1 (da)
FI (1) FI62089C (da)
FR (1) FR2294706A1 (da)
GB (1) GB1517710A (da)
GR (1) GR59204B (da)
HU (1) HU174673B (da)
IE (1) IE43208B1 (da)
IL (1) IL48697A (da)
LU (1) LU73972A1 (da)
NL (1) NL7514837A (da)
NO (1) NO144928C (da)
NZ (1) NZ179599A (da)
PH (1) PH11810A (da)
PL (1) PL99165B1 (da)
RO (1) RO68381A (da)
SE (1) SE420493B (da)
SU (1) SU603340A3 (da)
YU (1) YU39004B (da)
ZA (1) ZA757865B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4337254A (en) * 1977-08-23 1982-06-29 Burroughs Wellcome Co. Pharmaceutical compositions
DE3113880A1 (de) * 1981-04-07 1982-10-21 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von coffein
IT1174773B (it) * 1983-07-29 1987-07-01 Medosan Ind Biochimi Attivita' antiaggregante piastrinica e broncolitica della 7-(1-metil-5-p-metilbenzoilpirrol-2-acetamidoetil)teofillina
US5736528A (en) * 1993-10-28 1998-04-07 University Of Florida Research Foundation, Inc. N6 -(epoxynorborn-2-yl) adenosines as A1 adenosine receptor agonists
US5446046A (en) * 1993-10-28 1995-08-29 University Of Florida Research Foundation A1 adenosine receptor agonists and antagonists as diuretics
US5620676A (en) * 1994-03-08 1997-04-15 The United States Of America As Represented By The Department Of Health And Human Services Biologically active ATP analogs
US5789416B1 (en) * 1996-08-27 1999-10-05 Cv Therapeutics Inc N6 mono heterocyclic substituted adenosine derivatives
WO1999031101A1 (en) * 1997-12-17 1999-06-24 University Of South Florida Adenosine receptor antagonists with improved bioactivity
US6576619B2 (en) 1999-05-24 2003-06-10 Cv Therapeutics, Inc. Orally active A1 adenosine receptor agonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1230663A (da) * 1968-12-10 1971-05-05
US3728346A (en) * 1971-07-16 1973-04-17 Degussa Hydroxyphenylhydroxyalkylaminoalkyltheophyllines
JPS5132638B2 (da) * 1972-07-13 1976-09-14

Also Published As

Publication number Publication date
NO144928B (no) 1981-08-31
NL7514837A (nl) 1976-06-23
ATA904575A (de) 1977-06-15
DE2460929C2 (da) 1987-12-17
SE420493B (sv) 1981-10-12
CH628346A5 (de) 1982-02-26
YU39004B (en) 1983-12-31
FR2294706A1 (fr) 1976-07-16
FR2294706B1 (da) 1978-12-01
PL99165B1 (pl) 1978-06-30
IE43208L (en) 1976-06-21
JPS5188995A (da) 1976-08-04
HU174673B (hu) 1980-03-28
GB1517710A (en) 1978-07-12
NZ179599A (en) 1978-03-06
ZA757865B (en) 1977-08-31
YU323475A (en) 1982-08-31
FI753543A (da) 1976-06-22
IL48697A (en) 1979-07-25
NO144928C (no) 1981-12-09
DK137677B (da) 1978-04-17
SU603340A3 (ru) 1978-04-15
AU8754775A (en) 1977-06-23
IL48697A0 (en) 1976-02-29
LU73972A1 (da) 1977-02-15
PH11810A (en) 1978-07-10
DE2460929A1 (de) 1976-06-24
CS191289B2 (en) 1979-06-29
FI62089C (fi) 1982-11-10
ES451457A1 (es) 1977-10-01
US3998953A (en) 1976-12-21
SE7514477L (sv) 1976-06-22
DD124984A5 (da) 1977-03-23
NO754317L (da) 1976-06-22
GR59204B (en) 1977-11-26
ES443738A1 (es) 1977-04-16
FI62089B (fi) 1982-07-30
DK571875A (da) 1976-06-22
CA1036159A (en) 1978-08-08
IE43208B1 (en) 1981-01-14
DK137677C (da) 1978-09-25
BE836898A (fr) 1976-06-21
AT341540B (de) 1978-02-10
RO68381A (ro) 1982-02-26
AU501889B2 (en) 1979-07-05

Similar Documents

Publication Publication Date Title
BG25094A3 (en) A method of obtaining substituted purines
BG25092A3 (en) A method of obtaining hinazolon derivatives
BG27744A3 (en) Method of obtaining of hynazolin derivatives
BG25216A3 (en) A method of obtaining mercaptoazetidyne derivatives
BG24950A3 (en) A method of obtaining 1,3,4-trisubstituted-4-arilpiperidines
BG24812A3 (en) Method of obtaining 8-thiomethylergolins
BG24959A3 (en) A method of obtaining aminosacchars
BG25071A3 (en) A method of obtaining salicileanyl derivatives
BG25082A3 (en) A method of obtaining 1-aroyl-2-arylamine-2-imidazole derivatives
BG24542A3 (en) Method of preparing carbonylaldiminomethanphosphonates
BG25797A3 (en) A method of obtaining azapurinoni
CS188235B2 (en) Method of producing new derivatives ryfamicine
ZA753873B (en) A method of preparing plaster
CS191882B2 (en) Method of preparing 7-methoxy-6-thia-tetracycline
BG24807A3 (en) Method of obtaining pyridobenzodiazepinones
BG25070A3 (en) A method of obtaining alpha-6-deoxytetracyclines
BG25513A3 (en) A method of obtaining thiolcarbamates
BG25518A3 (en) A method of obtaining xantain derivatives
GR59205B (en) New preparation method of methoxy-2-benzamides derivative
BG25091A3 (en) A method of obtaining 7-acylamide-3-fluorcephalosporic compounds
BG25199A3 (en) A method of obtaining derivatives of antibiotic a 204 i
BG25081A3 (en) A method of obtaining isohinolines
BG25080A3 (en) A method of obtaining of pyridincarboxamide sulphonylcarbamides
JPS51125089A (en) Preparation method of piperazinopyrimidine derivatives
BG25793A3 (en) A method of obtaining carbasole derivatives